Armando Santoro

Professore

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

ciro franzese

Assistant Professor

Humanitas University

ITALY

View details

Anna Falanga

Full Professor of Hematology

University of Milano-Bicocca

ITALY

View details

Martina Sollini

Associate Professor in Diagnostic Imaging and Radiotherapy

Vita-Salute San Raffaele University

ITALY

View details

Alessandro Armuzzi

Humanitas University

ITALY

View details

Alberto Zambelli

Humanitas University

ITALY

View details

Rita De Sanctis

Humanitas University

ITALY

View details

Andrea D'Alessio

Vita-Salute San Raffaele University

ITALY

View details

ALESSIA ARTESANI

Assistant Professor

Humanitas University

ITALY

View details

Antonino Spinelli

Full Professor od Surgery

Humanitas University

ITALY

View details

Lorenza Rimassa

Humanitas University

ITALY

View details

Salvatore Piscuoglio

University of Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Armando Santoro

Research Interests

Explore related searches

Contact this professor

Articles (10)

Unlocking the Potential of Circulating miRNAs in the Breast Cancer Neoadjuvant Setting: A Systematic Review and Meta-Analysis

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from pivotal phase 2 CheckMate 205 study.

Opportunities and Challenges of Synthetic Data Generation in Oncology.

Imaging Correlates between Headache and Breast Cancer: An [<sup>18</sup>F]FDG PET Study

Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study).

Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients.

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management.

Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design.

Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

Collaborators (11)

ciro franzese

Anna Falanga

Martina Sollini

Alessandro Armuzzi

Alberto Zambelli

Rita De Sanctis

Andrea D'Alessio

ALESSIA ARTESANI

Antonino Spinelli

Lorenza Rimassa

Salvatore Piscuoglio

Make your next move.